A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
| Status: | Completed |
|---|---|
| Conditions: | Chronic Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - 38 |
| Updated: | 2/7/2015 |
| Start Date: | July 2014 |
| End Date: | November 2014 |
| Contact: | Eddy Lee |
| Email: | eddylee@ixbiopharma.com |
A Randomized,Double Blind, Parallel Group, Placebo Controlled Dose Ranging Study to Assess the Analgesic Efficacy, Tolerability, Safety and Pharmacokinetic/Pharmacodynamic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging,
placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of
ketamine sublingual wafer in adult subjects who experience post operative pain after
undergoing third molar extraction.
placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of
ketamine sublingual wafer in adult subjects who experience post operative pain after
undergoing third molar extraction.
18- 38 years of age Scheduled to undergo two ipsilateral third molar extractions
We found this trial at
1
site
Click here to add this to my saved trials
